Concepedia

Shaoli Lu

SL

Statistics

Publications

7

Citations

705

H-Index

7

Active since

2004

Affiliations

Peking University(Current)

The Ohio State University

Shaoli Lu is an author at Peking University specializing in epigenetics, oncology, and cancer epigenetics.

Publications per year

2004–2015

7

Publications

7

Acetylation of p53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of p21<sup>Waf1/Cip1</sup>

Ying Zhao, Shaoli Lu, Lipeng Wu et al. · Molecular and Cellular Biology · 2006 · 275 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

5-Aza-2′-deoxycytidine Activates the p53/p21Waf1/Cip1 Pathway to Inhibit Cell Proliferation

Wei‐Guo Zhu, Theresa Hileman, Yang Ke et al. · Journal of Biological Chemistry · 2004 · 149 citations · Full text

Medicine, Oncology, Pharmacology +17

Histone Deacetylase Inhibitor Depsipeptide Activates Silenced Genes through Decreasing both CpG and H3K9 Methylation on the Promoter

Lipeng Wu, Xi Wang, Lian Li et al. · Molecular and Cellular Biology · 2008 · 121 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

HDAC Inhibitors Act with 5-aza-2′-Deoxycytidine to Inhibit Cell Proliferation by Suppressing Removal of Incorporated Abases in Lung Cancer Cells

Guolin Chai, Lian Li, Wen Zhou et al. · PLoS ONE · 2008 · 70 citations · Full text

Medicine, Oncology, Pharmacology +16

An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of p53/p21Waf1/Cip1 in Response to 5-Aza-2′-deoxycytidine Treatment

Haiying Wang, Ying Zhao, Lian Li et al. · Journal of Biological Chemistry · 2007 · 60 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 7